It also re-examines some of the conventional wisdom that previously dominated clinical trial design and discusses development and internal validation of a predictive biomarker as a new paradigm for ...

This is the fourth in a series addressing the issues related to semiconductor design-for-yield. For the first three parts see pdf file. Statistical or six-sigma design requires the establishment of ...

Balancing Risk and Efficiency in Drug Development for Rare and Challenging Tumors: A New Paradigm for Glioma Innovations in molecular biology and immunology have revealed that distinct cancer ...